Ovarian cancer biology and immunotherapy
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2014-06-09 / Int. Rev. Immunol. 2014 Oct;33(5):428-40Regulatory T-cell inhibition plus antitumor immunotherapy targeted against cytomegalovirus (CMV) in patients with newly diagnosed glioblastoma multiforme (GBM).
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3069)A randomized, double-blind, placebo-controlled phase 2 trial of dendritic cell (DC) vaccination with ICT-107 in newly diagnosed glioblastoma (GBM) patients.
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 2005)Autologous dendritic cell vaccination (DCVAC/OvCa) added to standard of care therapy in three open-label randomized phase 2 studies in women with advanced stage ovarian cancer (OC).
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr TPS3134)Clinical use of dendritic cells for cancer therapy
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2014-06-01 / Lancet Oncol. 2014 Jun;15(7):e257-67Intratumoral vaccination with activated allogeneic dendritic cells in patients with newly diganosed metastatic renal cell carcinoma (mRCC).
/in Dendritic Cells, Hypernephroma, International Publications /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3085)Randomized phase II study with dendritic cell (DC) immunotherapy in patients with resected hepatic metastasis of colorectal carcinoma.
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr TPS3129)Combined chemoimmunotherapy of castrate-resistant prostate cancer with dendritic-cell based vaccine DCVAC/Pca.
/in Dendritic Cells, International Publications, Prostate Cancer /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3095)Cancer immunotherapy of patients with the biochemical relapse of the prostate cancer using dendritic cell-based vaccine DCVAC/PCa.
/in Dendritic Cells, International Publications, Prostate Cancer /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3099)IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de